157 related articles for article (PubMed ID: 37744402)
1. CDKs Functional Analysis in Low Proliferating Early-Stage Pancreatic Ductal Adenocarcinoma.
Zhu S; Yang H; Liu L; Jiang Z; Ji J; Wang X; Zhong L; Liu F; Gao X; Wang H; Zhou Y
J Bioinform Syst Biol; 2023; 6(3):187-200. PubMed ID: 37744402
[TBL] [Abstract][Full Text] [Related]
2. High expression of CDK1 and BUB1 predicts poor prognosis of pancreatic ductal adenocarcinoma.
Piao J; Zhu L; Sun J; Li N; Dong B; Yang Y; Chen L
Gene; 2019 Jun; 701():15-22. PubMed ID: 30898709
[TBL] [Abstract][Full Text] [Related]
3. RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.
Li X; Xiao Y; Fan S; Xiao M; Wang X; Chen X; Li C; Zong G; Zhou G; Wan C
Exp Mol Pathol; 2016 Oct; 101(2):176-186. PubMed ID: 27498047
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-183 is involved in cell proliferation, survival and poor prognosis in pancreatic ductal adenocarcinoma by regulating Bmi-1.
Zhou L; Zhang WG; Wang DS; Tao KS; Song WJ; Dou KF
Oncol Rep; 2014 Oct; 32(4):1734-40. PubMed ID: 25109303
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
6. A potential prognostic marker and therapeutic target: SPOCK1 promotes the proliferation, metastasis, and apoptosis of pancreatic ductal adenocarcinoma cells.
Li J; Ke J; Fang J; Chen JP
J Cell Biochem; 2020 Jan; 121(1):743-754. PubMed ID: 31478239
[TBL] [Abstract][Full Text] [Related]
7. Cyclin Dependent Kinase-1 (CDK-1) Inhibition as a Novel Therapeutic Strategy against Pancreatic Ductal Adenocarcinoma (PDAC).
Wijnen R; Pecoraro C; Carbone D; Fiuji H; Avan A; Peters GJ; Giovannetti E; Diana P
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503199
[TBL] [Abstract][Full Text] [Related]
8. Blockage of retinoic acid signaling via RARγ suppressed the proliferation of pancreatic cancer cells by arresting the cell cycle progression of the G1-S phase.
Yamakawa K; Koyanagi-Aoi M; Machinaga A; Kakiuchi N; Hirano T; Kodama Y; Aoi T
Cancer Cell Int; 2023 May; 23(1):94. PubMed ID: 37198667
[TBL] [Abstract][Full Text] [Related]
9. NF45 overexpression is associated with poor prognosis and enhanced cell proliferation of pancreatic ductal adenocarcinoma.
Wan C; Gong C; Ji L; Liu X; Wang Y; Wang L; Shao M; Yang L; Fan S; Xiao Y; Wang X; Li M; Zhou G; Zhang Y
Mol Cell Biochem; 2015 Dec; 410(1-2):25-35. PubMed ID: 26276310
[TBL] [Abstract][Full Text] [Related]
10. Post-translational modification of CDK1-STAT3 signaling by fisetin suppresses pancreatic cancer stem cell properties.
Xu X; Ding Y; Jin J; Xu C; Hu W; Wu S; Ding G; Cheng R; Cao L; Jia S
Cell Biosci; 2023 Sep; 13(1):176. PubMed ID: 37743465
[TBL] [Abstract][Full Text] [Related]
11. CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer.
Huang J; Chen P; Liu K; Liu J; Zhou B; Wu R; Peng Q; Liu ZX; Li C; Kroemer G; Lotze M; Zeh H; Kang R; Tang D
Gut; 2021 May; 70(5):890-899. PubMed ID: 32816920
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy.
Liao X; Han C; Wang X; Huang K; Yu T; Yang C; Huang R; Liu Z; Han Q; Peng T
Cancer Manag Res; 2018; 10():3255-3271. PubMed ID: 30233242
[TBL] [Abstract][Full Text] [Related]
13. Identify potential clinical significance of long noncoding RNA forkhead box P4 antisense RNA 1 in patients with early stage pancreatic ductal adenocarcinoma.
Liu XG; Xu H; Chen M; Tan XY; Chen XF; Yang YG; Lin MZ; Liu GH; Liang XL; Qian YB; Yuan GJ; Chen MQ; Li WT; Miao HL; Li MY; Liao XW; Dai W; Chen NP
Cancer Med; 2020 Mar; 9(6):2062-2076. PubMed ID: 31991068
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ILK and ERP29 expressions in benign and malignant pancreatic lesions and their clinicopathological significances in pancreatic ductal adenocarcinomas.
Zhang K; Yao H; Yang Z; Li D; Yang L; Zou Q; Yuan Y; Miao X
Clin Transl Oncol; 2016 Apr; 18(4):352-9. PubMed ID: 26887611
[TBL] [Abstract][Full Text] [Related]
15. Identification of the Roles of a Stemness Index Based on mRNA Expression in the Prognosis and Metabolic Reprograming of Pancreatic Ductal Adenocarcinoma.
Tang R; Liu X; Wang W; Hua J; Xu J; Liang C; Meng Q; Liu J; Zhang B; Yu X; Shi S
Front Oncol; 2021; 11():643465. PubMed ID: 33912458
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma.
Dong S; Huang F; Zhang H; Chen Q
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30765611
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting CDK4/6 in pancreatic ductal adenocarcinoma via microRNA-21.
Mortoglou M; Miralles F; Mould RR; Sengupta D; Uysal-Onganer P
Eur J Cell Biol; 2023 Jun; 102(2):151318. PubMed ID: 37105116
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.
Li X; Xiao Y; Fan S; Xiao M; Wang X; Zhu X; Chen X; Li C; Zong G; Zhou G; Wan C
Hum Pathol; 2016 Nov; 57():182-192. PubMed ID: 27498060
[TBL] [Abstract][Full Text] [Related]
19. High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC).
Gong C; Zhang Y; Chen Y; Zhang H; Liu X; Xue H; Ji L; Wang L; Yang L; Zhou G; Wan C
Tumour Biol; 2015 Dec; 36(12):9189-99. PubMed ID: 26088450
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma.
Weng S; Wang H; Chen W; Katz MH; Chatterjee D; Lee JE; Pisters PW; Gomez HF; Abbruzzese JL; Fleming JB; Wang H
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1336-43. PubMed ID: 22665577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]